Literature DB >> 404034

Species comparison of in vitro metabolism of aflatoxin B1.

B D Roebuck, G N Wogan.   

Abstract

The metabolism of [14C]aflatoxin B1 by 9000 X g supernatant fraction of livers of duck, rat, mouse, monkey, and humans was compared by incubating the compound and liver fractions in the presence of cofactors and air for 30 min. The incubation medium was extracted with chloroform, and the soluble metabolites were separated on thinlayer plates and quantified; radioactivity remaining in the aqueous phase was determined in order to quantify metabolism to water-soluble derivatives. Duck, monkey, and human livers were most active in total conversion, each metabolizing approximately 80% of available substrate in 30 min. Rat and mouse livers had lower activites, metabolizing 15 to 20%. Duck liver produced mainly (60%) chloroform-insoluble derivatives, but all other species produced larger quantities of chloroform-soluble than insoluble metabolites. Aflatoxin Q1 was the principle chloroform-soluble metabolite produced by monkey, human, and rat liver, whereas duck liver produced mainly aflatoxicol in that fraction. Aflatoxin P1 was produced by monkey, human, and mouse liver, but not by duck and rat. The chromatographic region containing M1 and B2alpha contained low levels of radioactivity in all species except human. No consistent pattern of metabolism emerged which could be correlated with species differences in response to aflatoxin B1 toxicity or carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404034

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Mutagenicity of aflatoxin B1, activated by S-9 fractions of human, rat, mouse, rabbit, and monkey liver, towards S. typhimurium TA 98.

Authors:  K Norpoth; R Grossmeier; H Bösenberg; H Themann; M Fleischer
Journal:  Int Arch Occup Environ Health       Date:  1979-01-15       Impact factor: 3.015

2.  Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.

Authors:  G E Neal; P J Colley
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

3.  Production and characterization of antibody against aflatoxin Q1.

Authors:  T S Fan; G S Zhang; F S Chu
Journal:  Appl Environ Microbiol       Date:  1984-03       Impact factor: 4.792

4.  Effect of dietary vitamin E (alpha-tocopherol) on aflatoxin B metabolism.

Authors:  G O Emerole; M I Thabrew; H O Kwanashie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

Review 5.  AFM₁ in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination.

Authors:  Laura Giovati; Walter Magliani; Tecla Ciociola; Claudia Santinoli; Stefania Conti; Luciano Polonelli
Journal:  Toxins (Basel)       Date:  2015-10-23       Impact factor: 4.546

6.  Predicting the Acute Liver Toxicity of Aflatoxin B1 in Rats and Humans by an In Vitro-In Silico Testing Strategy.

Authors:  Ixchel Gilbert-Sandoval; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Mol Nutr Food Res       Date:  2020-06-02       Impact factor: 5.914

7.  Research progress in toxicological effects and mechanism of aflatoxin B1 toxin.

Authors:  Congcong Li; Xiangdong Liu; Jiao Wu; Xiangbo Ji; Qiuliang Xu
Journal:  PeerJ       Date:  2022-08-04       Impact factor: 3.061

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.